2011 Annual Meeting Brochure
2012 Annual Meeting in Tampa, FL, April 29-May 2
Pre-Meeting Workshop: MTM Boot Camp The Business of Patient Care: Incorporating Comprehensive Medication Management (MTM) into your Practice
Where do you “fit” in the new health care system as a neuropsychiatric pharmacist? This day-long workshop will begin with an update on the health care system. The emphasis will be on the role of the pharmacist in the new organizational structures of the medical home and accountable care organizations.
The program will then demonstrate what payers want from pharmacists who wish to provide medication management services. Keys to defining your service, recruiting patients, demonstrating your value, charging for your services and expanding your service will all be demonstrated.
This workshop will provide critical information to pharmacists in all practice settings. You will get important questions answered and understand what changes are needed to achieve and maintain a successful practice. You will also have the opportunity to learn from individuals in the private sector who have experience in delivering medication management services. Join us with the goal of making your service even more successful in 2012.
Speakers at 2011 Annual Meeting
 |
Cara Alfaro, PharmD, BCPP, Clinical Analyst, Food and Drug Administration CDER/Division of Psychiatry Products, Silver Spring, MD The FDA: Inside the Black Box - A Discussion of Regulations and Recent Decisions |
 |
Ericka Breden, PharmD, BCPP, CGP, FASCP, Clinical Pharmacy Specialist, Virginia Commonwealth University Health System, Richmond, VA Clinical Pearl-Unique Side Effects of Olanzapine |
 |
Charles Caley, PharmD, BCPP, Associate Clinical Professor, University of Connecticut, Hartford, CT Clinical Pearl-Influence of CYP2 Genotyping on Psychiatric Pharmacists Consultations |
 |
M. Lynn Crismon, PharmD, BCPP, FCCP, Dean, Doluiso Regents Chair and Behrens Centennial Professor, University of Texas at Austin College of Pharmacy, Austin, TX Management of Aggression in Children |
 |
C. Lindsay DeVane, PharmD, BCPP, FCCP, Professor of Psychiatry, Medical University of South Carolina, Charleston, SC Drug Transporters and Psychiatry |
 |
Patrick Finley, PharmD, BCPP, Clinical Professor of Psychopharmacology and Behavioral Health, University of California at San Francisco, San Francisco, CA Incorporating Health Services Research into Practice-Part II |
 |
Jill Fowler, PharmD, Clinical Pharmacy Specialist-Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, IA Clinical Pearl-Clozapine-Induced Gastrointestinal Hypomotility: More Than Just Constipation |
 |
Joseph Goldberg, MD, Associate Clinical Professor of Psychiatry, Mount Sinai School of Medicine, New Rochelle, NY The Role of Antidepressants in Bipolar Disorder: Myth Versus Reality |
 |
Barry Gidal, PharmD, Professor, University of Wisconsin, Madison, WI Seizures and Psychiatry |
 |
Jessica Goren, PharmD, BCPP, Associate Professor, University of Rhode Island, Somerville, MA Use of Omega-3 Fatty Acids in Mental Illness |
 |
Amy Kilbourne, PhD, MPH, Investigator, VA Ann Arbor Health Services Research and Development, Ann Arbor, MI Incorporating Health Services Research into Practice-Part I |
 |
Eric Kutscher, PharmD, BCPP, Clinical Pharmacy Specialist, Psychiatry and Director, PGY2 Psychiatric Pharmacy Practice Residency Program, Avera Behavioral Health Center, Associate Professor of Pharmacy Practice, South Dakota State University College of Pharmacy, Adjunct Associate Professor of Psychiatry, Sanford-USD School of Medicine Sioux Falls, SD Putting the Action in Long-Acting Antipsychotic Injectables |
 |
Rex S. Lott, PharmD, BCPP, Professor of Pharmacy Practice, Department of Pharmacy Practice & Administrative Sciences, Idaho State University College of Pharmacy, Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Mental Health Clinical Pharmacist, Boise VA Medical Center, Boise, Idaho Antipsychotics and Beyond: Behavioral Disturbances in the Elderly-Part I |
 |
Jodie Malhotra, PharmD, Experiential Education Director, Regis University School of Pharmacy, Denver, CO Pre-Meeting Workshop: Optimizing Cardiovascular Health in Psychiatric Patients |
 |
Anna Morin, PharmD, Associate Professor, Massachusetts College of Pharmacy and Health Sciences, Worchester, MA Fibromyalgia: Pain and the Brain |
|
Jennifer Nelson, PharmD, BCPP, Clinical Pharmacy Specialist, Parkland Hospital System, Dallas, TX Clinical Pearl-The Misuse/Abuse of Psychiatric Medications in the Correctional Healthcare System |
|
 |
Melody Ryan, PharmD, BCPS, CGP, FASCP, Associate Professor, University of Kentucky College of Pharmacy, Lexington, KY Emerging Therapies for Multiple Sclerosis |
 |
Afshin Shirani, MD, Clinical Assistant Professor, Dartmouth College, Lebanon, NH Impact of Psychotropic Medications on Sleep Architecture |
 |
Tawny Smith, PharmD, BCPP, Clinical Pharmacy Specialist-Psychiatry, Seton Family of Hospitals, Austin, TX Pre-Meeting Workshop: Optimizing Cardiovascular Health in Psychiatric Patients |
 |
Stephen Stahl, MD, PhD, Department of Psychiatry University of California San Diego, CA and Department of Psychiatry, University of Cambridge, UK Glutamate: The Emerging Frontier of Psychopharmacology for Schizophrenia and Mood Disorders |
 |
Linda Strand, PhD, PharmD, Professor Emeritus, University of Minnesota, Vice President, Medication Management Systems, Minneapolis, MN Seizing the MTM Opportunity: What Psychiatric Pharmacists Need to Know |
 |
Robert Talbert, PharmD, FCCP, BCPS, FAHA, Professor, University of Texas at Austin College of Pharmacy, Austin, TX Pre-Meeting Workshop: Optimizing Cardiovascular Health in Psychiatric Patients |
 |
Ken Towbin, MD, Clinical Professor, George Washington University School of Medicine, Potomac, MD Irritability and Elation: The Consequences of Thinking about Pediatric Bipolar Disorder and Severe Mood Dysregulation |
 |
Christopher White, MD, JD, FCLM, Assistant Professor of Psychiatry & Family Medicine, University of Cincinnati, Cincinnati, OH Antipsychotics and Beyond: Behavioral Disturbances in the Elderly-Part II |